GPR119 regulates murine glucose homeostasis through incretin receptor-dependent and independent mechanisms

Endocrinology

Volumn 152, Issue 2, 2011, Pages 374-383

  Flock, Grace ^a   Holland, Dianne ^a   Seino, Yutaka ^a   Drucker, Daniel J ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; INCRETIN; INSULIN; PEPTIDE YY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; GLUCOSE URINE LEVEL; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET; PEPTIDERGIC NERVOUS SYSTEM; PRIORITY JOURNAL; STOMACH EMPTYING;

ANIMALS; BLOOD GLUCOSE; GASTRIC EMPTYING; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE TOLERANCE TEST; INSULIN; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OXADIAZOLES; PYRIMIDINES; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, GASTROINTESTINAL HORMONE;

EID: 79951636303     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-1047     Document Type: Article

References (41)

1. Pederson RA, Schubert HE, Brown JC 1975 Gastric inhibitory polypeptide. Its physiologic release and insulinotropic action in the dog. Diabetes 24:1050-1056
2. Drucker DJ 2006 The biology of incretin hormones. Cell Metab 3:153-165
3. Deacon CF 2004 Therapeutic strategies based on glucagon-like peptide 1. Diabetes 53:2181-2189 (Pubitemid 39145569)
4. Drucker DJ, Nauck MA 2006 The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368:1696-1705 (Pubitemid 46048557)
5. Ahrén B 2009 Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes. Nat Rev Drug Discov 8:369-385
6. Fredriksson R, Höglund PJ, Gloriam DE, Lagerström MC, Schiöth HB 2003 Seven evolutionarily conserved human rhodopsin G protein-coupled receptors lacking close relatives. FEBS Lett 554:381-388 (Pubitemid 37412518)
7. Chu ZL, Jones RM, He H, Carroll C, Gutierrez V, Lucman A, Moloney M, Gao H, Mondala H, Bagnol D, Unett D, Liang Y, Demarest K, Semple G, Behan DP, Leonard J 2007 A role for β-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose dependent insulin release. Endocrinology 148:2601-2609 (Pubitemid 46984798)
8. Overton HA, Babbs AJ, Doel SM, Fyfe MC, Gardner LS, Griffin G, Jackson HC, Procter MJ, Rasamison CM, Tang-Christensen M, Widdowson PS, Williams GM, Reynet C 2006 Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab 3:167-175
9. Soga T, Ohishi T, Matsui T, Saito T, Matsumoto M, Takasaki J, Matsumoto S, Kamohara M, Hiyama H, Yoshida S, Momose K, Ueda Y, Matsushime H, Kobori M, Furuichi K 2005 Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor. Biochem Biophys Res Commun 326:744-751 (Pubitemid 39655983)
10. Ning Y, O'Neill K, Lan H, Pang L, Shan LX, Hawes BE, Hedrick JA 2008 Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells. Br J Pharmacol 155:1056-1065
11. Lauffer LM, Iakoubov R, Brubaker PL 2009 GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell. Diabetes 58:1058-1066
12. Chu ZL, Carroll C, Chen R, Alfonso J, Gutierrez V, He H, Lucman A, Xing C, Sebring K, Zhou J, Wagner B, Unett D, Jones RM, Behan DP, Leonard J 2010 N-oleoyldopamine enhances glucose homeostasis through the activation of GPR119. Mol Endocrinol 24:161-170
13. Semple G, Fioravanti B, Pereira G, Calderon I, Uy J, Choi K, Xiong Y, Ren A, Morgan M, Dave V, Thomsen W, Unett DJ, Xing C, Bossie S, Carroll C, Chu ZL, Grottick AJ, Hauser EK, Leonard J, Jones RM 2008 Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119. J Med Chem 51:5172-5175
14. Chu ZL, Carroll C, Alfonso J, Gutierrez V, He H, Lucman A, Pedraza M, Mondala H, Gao H, Bagnol D, Chen R, Jones RM, Behan DP, Leonard J 2008 A role for intestinal endocrine cell-expressed GPR119 in glycemic control by enhancing GLP-1 and GIP release. Endocrinology 149:2038-2047
15. Parker HE, Habib AM, Rogers GJ, Gribble FM, Reimann F 2009 Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murineKcells. Diabetologia 52:289-298
16. Reimann F, Habib AM, Tolhurst G, Parker HE, Rogers GJ, Gribble FM 2008 Glucose sensing in L cells: a primary cell study. Cell Metab 8:532-539
17. Lan H, Vassileva G, Corona A, Liu L, Baker H, Golovko A, Abbondanzo SJ, Hu W, Yang S, Ning Y, Del Vecchio RA, Poulet F, Laverty M, Gustafson EL, Hedrick JA, Kowalski TJ 2009 GPR119 is required for physiological regulation of glucagon-like peptide-1 secretion but not for metabolic homeostasis. J Endocrinol 201:219-230
18. Cox HM, Tough IR, Woolston AM, Zhang L, Nguyen AD, Sainsbury A, Herzog H 2010 Peptide YY is critical for acylethanolamine receptor Gpr119-induced activation of gastrointestinal mucosal responses. Cell Metab 11:532-542
19. Hansotia T, Maida A, Flock G, Yamada Y, Tsukiyama K, Seino Y, Drucker DJ 2007 Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure. J Clin Invest 117:143-152 (Pubitemid 46048461)
20. Yusta B, Holland D, Koehler JA, Maziarz M, Estall JL, Higgins R, Drucker DJ 2009 ErbB signaling is required for the proliferative actions of GLP-2 in the murine gut. Gastroenterology 137:986-996
21. Kim BJ, Carlson OD, Jang HJ, Elahi D, Berry C, Egan JM 2005 Peptide YY is secreted after oral glucose administration in a genderspecific manner. J Clin Endocrinol Metab 90:6665-6671
22. Maida A, Hansotia T, Longuet C, Seino Y, Drucker DJ 2009 Differential importance of GIP versus GLP-1 receptor signaling for β cell survival in mice. Gastroenterology 137:2146-2157
23. Hall WL, Millward DJ, Long SJ, Morgan LM 2003 Casein and whey exert different effects on plasma amino acid profiles, gastrointestinal hormone secretion and appetite. Br J Nutr 89:239-248 (Pubitemid 36215862)
24. Blase E, Taylor K, Gao HY, Wintle M, Fineman M 2005 Pharmacokinetics of an oral drug (acetaminophen) administered at various times in relation to subcutaneous injection of exenatide (exendin-4) in healthy subjects. J Clin Pharmacol 45:570-577 (Pubitemid 40562948)
25. Hansotia T, Baggio LL, Delmeire D, Hinke SA, Yamada Y, Tsukiyama K, Seino Y, Holst JJ, Schuit F, Drucker DJ 2004 Double incretin receptor knockout (DIRKO) mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-IV inhibitors. Diabetes 53:1326-1335 (Pubitemid 38569020)
26. Preitner F, Ibberson M, Franklin I, Binnert C, Pende M, Gjinovci A, Hansotia T, Drucker DJ, Wollheim C, Burcelin R, Thorens B 2004 Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors. J Clin Invest 113:635-645 (Pubitemid 38542513)
27. Wettergren A, Schjoldager B, Mortensen PE, Myhre J, Christiansen J, Holst JJ 1993 Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci 38:665-673 (Pubitemid 23121274)
28. Nauck MA, Wollschläger D, Werner J, Holst JJ, Orskov C, Creutzfeldt W, Willms B 1996 Effects of subcutaneous glucagonlike peptide 1 (GLP-1[7-36 amide]) in patients with NIDDM. Diabetologia 39:1546-1553 (Pubitemid 26397366)
29. Wojdemann M, Wettergren A, Hartmann B, Holst JJ 1998 Glucagon like peptide-2 inhibits centrally induced antral motility in pigs. Scand J Gastroenterol 33:828-832 (Pubitemid 28423636)
30. Wang L, Gourcerol G, Yuan PQ, Wu SV, Million M, Larauche M, Taché Y 2010 Peripheral peptide YY inhibits propulsive colonic motor function through Y2 receptor in conscious mice. Am J Physiol Gastrointest Liver Physiol 298:G45-G56
31. Pederson RA, Satkunarajah M, McIntosh CH, Scrocchi LA, Flamez D, Schuit F, Drucker DJ, Wheeler MB 1998 Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice. Diabetes 47:1046-1052 (Pubitemid 28294546)
32. Pamir N, Lynn FC, Buchan AM, Ehses J, Hinke SA, Pospisilik JA, Miyawaki K, Yamada Y, Seino Y, McIntosh CH, Pederson RA 2003 Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis. Am J Physiol Endocrinol Metab 284:E931-E939 (Pubitemid 36444028)
33. Deacon CF, Wamberg S, Bie P, Hughes TE, Holst JJ 2002 Preservation of active incretin hormones by inhibition of dipeptidyl peptidase IV suppresses meal-induced incretin secretion in dogs. J Endocrinol 172:355-362 (Pubitemid 34183084)
34. Wheeler MB, Gelling RW, McIntosh CH, Georgiou J, Brown JC, Pederson RA 1995 Functional expression of the rat pancreatic islet glucose-dependent insulinotropic polypeptide receptor: ligand binding and intracellular signaling properties. Endocrinology 136:4629-4639
35. Ban K, Kim H, Cho J, Sauvé M, Diamandis E, Backx PH, Drucker DJ, Husain M 2010 GLP-1(9-36) protects cardiomyocytes and endothelial cells from ischemia-reperfusion injury via cytoprotective pathways independent of the GLP-1 receptor. Endocrinology 151:1520-1531
36. Sakamoto Y, Inoue H, Kawakami S, Miyawaki K, Miyamoto T, Mizuta K, Itakura M 2006 Expression and distribution of Gpr119 in the pancreatic islets of mice and rats: predominant localization in pancreatic polypeptide-secreting PP-cells. Biochem Biophys Res Commun 351:474-480 (Pubitemid 44666712)
37. Edwards CM, Todd JF, Mahmoudi M, Wang Z, Wang RM, Ghatei MA, Bloom SR 1999 Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39. Diabetes 48:86-93 (Pubitemid 29019356)
38. Salehi M, Prigeon RL, Aulinger B, D'Alessio DA 2010 Effect of endogenous GLP-1 on insulin secretion in type 2 diabetes. Diabetes 59:1330-1337
39. Schwartz GJ, Fu J, Astarita G, Li X, Gaetani S, Campolongo P, Cuomo V, Piomelli D 2008 The lipid messenger OEA links dietary fat intake to satiety. Cell Metab 8:281-288
40. Cluny NL, Keenan CM, Lutz B, Piomelli D, Sharkey KA 2009 The identification of peroxisome proliferator-activated receptor β-independent effects of oleoylethanolamide on intestinal transit in mice. Neurogastroenterol Motil 21:420-429
41. Talsania T, Anini Y, Siu S, Drucker DJ, Brubaker PL 2005 Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice. Endocrinology 146:3748-3756 (Pubitemid 41175742)